Monograph
N07AA51 - Neostigmine, Combinations |
Propably not porphyrinogenic |
PNP |
Rationale
Neostigmine: Probably not interfering with hepatic CYPs. References consider it safe. Glycopyrrone: Not metabolised. References consider it safe
Chemical description
A combination of an anticholinergic and a cholinesterase inhibitor used for reversal of non-depolarisation neuromuscular blockade Neostigmine: Cholinesterase inhibitor of short duration. No data pointing to CYP-interaction. Glucopyrrone: Quarternary ammonium compound with anticholinergic properties. Ionized at physiological pH. Rapidly excreted in unchanged form in urine. Neostigmine: MFM James, RJ Hift. Porphyrias. Br J Anaesth 2000; 85, 143-53: use EPI-list: safe South African list: use Glycopyrrone: MFM James, RJ Hift. Porphyrias. Br J Anaesth 2000; 85, 143-53: use EPI-list: safe
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
© NAPOS 2025